Fred Aslan Artiva Biotherapeutics, Inc. (RTVA) insider trading activity

Shares Held (Direct Ownership) 344K

10.0% 3M change

50.28% 12M change

Total Value Held N/A

Fred Aslan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 17 2025	SELL Open market or private sale	$21,547 $3.38 p/Share	6,375 Reduced 1.82%	343,999 Common Stock
Nov 15 2025	SELL Payment of exercise price or tax liability	$20,627 $3.25 p/Share	6,347 Reduced 1.78%	350,374 Common Stock
Oct 17 2025	SELL Open market or private sale	$153,000 $6.0 p/Share	25,500 Reduced 6.67%	356,721 Common Stock
Aug 15 2025	SELL Payment of exercise price or tax liability	$12,298 $2.75 p/Share	4,472 Reduced 1.16%	382,221 Common Stock
Aug 15 2025	SELL Open market or private sale	$69,615 $2.73 p/Share	25,500 Reduced 6.19%	386,693 Common Stock
May 15 2025	SELL Payment of exercise price or tax liability	$9,525 $2.13 p/Share	4,472 Reduced 1.07%	412,193 Common Stock
Mar 05 2025	BUY Grant, award, or other acquisition	-	200,000 Added 32.43%	416,665 Common Stock
Jul 22 2024	BUY Grant, award, or other acquisition	-	228,905 Added 50.0%	228,905 Common Stock

President and CEO

San Diego, CA

Receive a notification when an Institution or Guru buys or sells RTVA shares.

Notify only if

Value

Get notified when an Artiva Biotherapeutics, Inc. insider buys or sells RTVA shares.

Notify only if

Operation

Value

Type

Receive news related to Artiva Biotherapeutics, Inc.